GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20527
Submission : 2007-05-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3420
Submission : 1978-10-25
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3420
Submission : 1978-10-25
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20527
Submission : 2007-05-11
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
Drug : TADALAFIL
Dosage Form : TABLET; ORAL
Application Number : 206286
Country : US
Patented : No
Drug : LOPERAMIDE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 21855
Country : US
Patented : No
Drug : TRAVOPROST
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 91340
Country : US
Patented : No
Drug : FENOFIBRATE
Dosage Form : TABLET; ORAL
Application Number : 217732
Country : US
Patented : No
Drug : FELODIPINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90365
Country : US
Patented : No
Drug : LIDOCAINE AND PRILOCAINE
Dosage Form : CREAM; TOPICAL
Application Number : 76290
Country : US
Patented : No
Drug : CYCLOSPORINE
Dosage Form : CAPSULE; ORAL
Application Number : 65110
Country : US
Patented : No
Drug : FELODIPINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 203983
Country : US
Patented : No
Drug : NEORAL
Dosage Form : CAPSULE; ORAL
Application Number : 50715
Country : US
Patented : No
Drug : CYCLOSPORINE
Dosage Form : CAPSULE; ORAL
Application Number : 65017
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
Brand Name : Polyoxyethylene (40) Hydrogenated Castor Oil
Application : Topical
Excipient Details : Polyoxyethylene (40) Hydrogenated Castor Oil is used as a wetting agent in OSDs. It is also used in SEDDS & as a solubilizer in topical dosage forms.
Pharmacopoeia Ref : ChP/USP/EP
Technical Specs : NA
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Application : Topical
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
MARKET PLACE
Reply
01 Apr 2025
Reply
18 Jun 2022
Reply
18 Feb 2022